5-(3-Pyridin-3-yl-allylidene)-2-thioxo-dihydro-pyrimidine-4,6-dione

ID: ALA4176101

PubChem CID: 117931617

Max Phase: Preclinical

Molecular Formula: C12H9N3O2S

Molecular Weight: 259.29

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1NC(=S)NC(=O)C1=C/C=C/c1cccnc1

Standard InChI:  InChI=1S/C12H9N3O2S/c16-10-9(11(17)15-12(18)14-10)5-1-3-8-4-2-6-13-7-8/h1-7H,(H2,14,15,16,17,18)/b3-1+

Standard InChI Key:  YHNNYZJHKOLXBZ-HNQUOIGGSA-N

Molfile:  

     RDKit          2D

 18 19  0  0  0  0  0  0  0  0999 V2000
    6.2642   -9.8752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9720   -9.4677    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.6839   -9.8752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6839  -10.6943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9720  -11.1018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2642  -10.6943    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.3916   -9.4677    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.9720  -11.9209    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5564   -9.4677    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    8.3916  -11.1018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0994  -10.6943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8072  -11.1018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2269  -11.1018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5191  -10.6943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5191   -9.8752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2269   -9.4677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9346   -9.8752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9346  -10.6943    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  1  6  1  0
  3  7  2  0
  5  8  2  0
  1  9  2  0
 10 11  1  0
 11 12  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 13 18  2  0
 12 14  1  0
  4 10  2  0
M  END

Associated Targets(Human)

CHL-1 (186 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UACC-903 (393 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 259.29Molecular Weight (Monoisotopic): 259.0415AlogP: 0.55#Rotatable Bonds: 2
Polar Surface Area: 71.09Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 7.44CX Basic pKa: 4.88CX LogP: 0.98CX LogD: 0.71
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.46Np Likeness Score: -0.94

References

1. Ramisetti SR, Pandey MK, Lee SY, Karelia D, Narayan S, Amin S, Sharma AK..  (2018)  Design and synthesis of novel thiobarbituric acid derivatives targeting both wild-type and BRAF-mutated melanoma cells.,  143  [PMID:29133035] [10.1016/j.ejmech.2017.11.006]

Source